Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › lonapegsomatropin

lonapegsomatropin

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of lonapegsomatropin

2 trials tracked of lonapegsomatropin: 2 in phase 3 or 4.

2Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 2
  1. Phase 3 A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency Completed
  2. Phase 3 A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Meta-analysis indicates increased BMI SD scores with long-acting growth hormone versus daily rhGH in children
Pediatrics Meta-analysis
Meta-analysis indicates increased BMI SD scores with long-acting growth hormone versus daily rhGH in children New Growth Hormone Treatment Tied to Weight Gain in Kids
This meta-analysis evaluated body mass index (BMI) SD scores in 585 children with growth hormone deficiency treated with long-acting growth …
This treatment could change how kids grow — but it might also affect their weight.
Apr 22, 2026